| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $1.1B | $1.2B | $1.1B | $1.3B | $1.2B | $1.2B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.5B | $0.1B | $0.2B | $0.4B | $0.4B | $0.3B | $0.3B | $0.3B |
| EPS (Basic) | $2.79 | $0.73 | $1.14 | $2.36 | $2.20 | $1.87 | $1.93 | $1.92 |
| EPS (Diluted) | $2.77 | $0.72 | $1.13 | $2.34 | $2.18 | $1.86 | $1.91 | $1.89 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $45.2B | $43.0B | $41.0B | $39.4B | $35.1B | $33.4B | $32.4B | $33.6B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | — |
| Total Liabilities | $40.2B | $38.4B | $36.8B | $35.4B | $31.1B | $29.3B | $28.5B | $29.9B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $5.0B | $4.6B | $4.2B | $4.0B | $4.0B | $4.1B | $3.9B | $3.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.6B | $0.6B | $0.4B | $0.8B | $0.5B | $0.6B | $0.6B | $0.5B |
| Investing Cash Flow | $-1.6B | $-2.2B | $-1.4B | $-5.3B | $-1.6B | $-0.8B | $1.6B | $-0.4B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $1.7B | $1.7B | $1.3B | $4.0B | $1.4B | $0.4B | $-2.5B | $0.0B |